- Home
- QNCX vs DIBS Comparison
QNCX vs DIBS Comparison
Compare QNCX & DIBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- DIBS
- Stock Information
- Founded
- QNCX 2012
- DIBS 2000
- Country
- QNCX United States
- DIBS United States
- Employees
- QNCX N/A
- DIBS N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- DIBS Catalog/Specialty Distribution
- Sector
- QNCX Health Care
- DIBS Consumer Discretionary
- Exchange
- QNCX Nasdaq
- DIBS Nasdaq
- Market Cap
- QNCX 88.6M
- DIBS 99.7M
- IPO Year
- QNCX 2019
- DIBS 2021
- Fundamental
- Price
- QNCX $1.60
- DIBS $3.55
- Analyst Decision
- QNCX Strong Buy
- DIBS Hold
- Analyst Count
- QNCX 6
- DIBS 1
- Target Price
- QNCX $8.00
- DIBS N/A
- AVG Volume (30 Days)
- QNCX 271.4K
- DIBS 87.2K
- Earning Date
- QNCX 11-12-2025
- DIBS 11-07-2025
- Dividend Yield
- QNCX N/A
- DIBS N/A
- EPS Growth
- QNCX N/A
- DIBS N/A
- EPS
- QNCX N/A
- DIBS N/A
- Revenue
- QNCX N/A
- DIBS $88,640,000.00
- Revenue This Year
- QNCX N/A
- DIBS $2.87
- Revenue Next Year
- QNCX N/A
- DIBS $3.26
- P/E Ratio
- QNCX N/A
- DIBS N/A
- Revenue Growth
- QNCX N/A
- DIBS 3.21
- 52 Week Low
- QNCX $0.72
- DIBS $2.30
- 52 Week High
- QNCX $2.45
- DIBS $4.39
- Technical
- Relative Strength Index (RSI)
- QNCX 37.36
- DIBS 67.13
- Support Level
- QNCX $1.76
- DIBS $2.55
- Resistance Level
- QNCX $1.88
- DIBS $4.10
- Average True Range (ATR)
- QNCX 0.10
- DIBS 0.23
- MACD
- QNCX -0.03
- DIBS 0.06
- Stochastic Oscillator
- QNCX 9.28
- DIBS 62.71
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About DIBS 1stdibs.com Inc.
1stdibs.com Inc is an online marketplace for connecting design lovers with the sellers and makers of vintage, antique, and contemporary furniture, home decor, jewelry, watches, art, and fashion. The Company has a single reportable and operating segment that contains one reporting unit, which consists of the Company's online marketplace that enables commerce between sellers and buyers. The company generates maximum revenue from fees from seller marketplace services and other services, including advertisements.